| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| upadacitinib 15 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| fosnetupitant 235 mg + palonosetron 250 microgram injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| docusate sodium 2.5% ear drops |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| Saccharomyces boulardii 500 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| mepolizumab 100 mg/mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| mepolizumab 100 mg/mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lidocaine (lignocaine) hydrochloride 4% + tetracaine (amethocaine) hydrochloride 0.5% + adrenaline (epinephrine) acid tartrate 0.18% solution, 5 mL vial |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amino acid formula with fat, carbohydrate without valine, leucine and isoleucine modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amino acid formula with carbohydrate without phenylalanine modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amino acid formula with fat, carbohydrate without methionine modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amino acid formula with fat, carbohydrate without phenylalanine and tyrosine modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| glucarpidase 1000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| turmeric extract 112.5 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| thiamine 2.08 mg + riboflavin 2 mg + nicotinamide 2 mg + pantothenic acid 1.83 mg + folic acid 50 microgram + ascorbic acid 10 mg + dl-alpha-tocopherol 1.876 mg + iron 650 microgram + magnesium 3.1 mg + zinc 25 mg + creatine monohydrate 50 mg + taurine 5.74 mg + isoleucine 1 mg + cysteine 5.387 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| turmeric extract 100 mg + black myrobalan extract 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| white willow extract 240 mg + black myrobalan extract 200 mg + turmeric extract 25 mg + ginger extract 50 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| succimer 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ferrous gluconate 191.73 mg (iron 24 mg) + ascorbic acid 70 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| terbutaline sulfate 400 microgram/actuation powder for inhalation, actuation |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amino acid formula with vitamins and minerals without phenylalanine powder for oral liquid, 28 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bupivacaine hydrochloride 0.5% (20 mg/4 mL) injection, ampoule |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 12.5 mg sublingual wafer |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| nicotinamide 50 mg + isoleucine 49 mg + leucine 35 mg + valine 35 mg + thiamine 25 mg + ascorbic acid 22.5 mg + alanine 21 mg + glycine 12 mg + pantothenic acid 6 mg + d-alpha-tocopheryl acetate 2.5 mg + iron 2.25 mg + riboflavin 1.3 mg + betacarotene 225 microgram + biotin 15 microgram + cyanocobalamin 12 microgram + ergocalciferol 2.5 microgram (100 IU) capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| argatroban monohydrate 100 mg/mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| edrophonium chloride 10 mg/mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| edrophonium chloride 10 mg/mL injection, 15 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| silibinin 350 mg powder for injection, vial |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| midazolam 50 mg/10 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| midazolam 5 mg/5 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lorazepam 500 microgram tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| colestyramine 8 g powder for oral liquid, sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| colestyramine 4 g powder for oral liquid, sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ketamine 100 mg/100 mL injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| guselkumab 100 mg/mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lorlatinib 100 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| remdesivir 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| remdesivir 100 mg/20 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| entrectinib 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lorlatinib 25 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 0.3 mg/mL + cannabidiol 53.5 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vedolizumab 108 mg/0.68 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| entrectinib 100 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| argatroban 250 mg/2.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vedolizumab 108 mg/0.68 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| midodrine hydrochloride 2.5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| methylprednisolone acetate 40 mg/mL modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lactulose 3.3 g/5 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 3000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 2000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 500 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol less than 3 mg/mL spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 1500 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 12 mg/mL + cannabidiol 20 mg/mL spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 3 mg/mL + cannabidiol 20 mg/mL spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| zolpidem tartrate 5 mg/actuation spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| taurolidine 1.35% (40.5 mg/3 mL) + citric acid 4% (120 mg/3 mL) irrigation solution, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| taurolidine 1.35% (67.5 mg/5 mL) + citric acid 4% (200 mg/5 mL) irrigation solution, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ibrutinib 560 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ibrutinib 420 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ibrutinib 140 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ibrutinib 280 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| baloxavir marboxil 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| baloxavir marboxil 40 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tafamidis meglumine 20 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tafamidis 61 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| gilteritinib 40 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| alpelisib 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| alpelisib 50 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| alpelisib 150 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ciclosporin 0.09% eye drops, unit dose |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| darolutamide 300 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| isatuximab 500 mg/25 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| titanium dioxide 9.8% + zinc oxide 2% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dinutuximab beta 20 mg/4.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| isatuximab 100 mg/5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vonicog alfa 650 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vonicog alfa 1300 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| retinol acetate 375 microgram RE + thiamine nitrate 10 mg + riboflavin 10 mg + nicotinamide 25 mg + calcium pantothenate 8 mg + pyridoxine hydrochloride 2 mg + cyanocobalamin 2 microgram + ascorbic acid 75 mg + colecalciferol 10 microgram (400 units) + dl-alpha-tocopheryl acetate 10 mg (10 units) + calcium 10 mg + phosphorus 7.7 mg + copper 1 mg + iron 5 mg + iodine 145 microgram + magnesium 36 mg + manganese 1 mg + potassium 5 mg + zinc 1.5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| gemtuzumab ozogamicin 5 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lipase 35 000 units + amylase 25 200 units + protease 1400 units enteric capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| silibinin 350 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| metronidazole 500 mg/100 mL injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lipase 20 000 units + amylase 16 000 units + protease 1200 units enteric capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| brolucizumab 6 mg/0.05 mL injection, syringe |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| inert substance diluent, 1.7 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| voretigene neparvovec 5 trillion vector genomes/mL injection, 0.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| aflibercept 3.6 mg/0.09 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 6 mg/mL + cannabidiol 200 mg/mL oral oil |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral oil |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ripretinib 50 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| mecasermin 10 mg/mL injection, 4 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 15 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lanadelumab 300 mg/2 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| Lactobacillus rhamnosus 15.55 billion CFU + Lactobacillus casei 9.45 billion CFU + Lactobacillus acidophilus 7.4 billion CFU + Lactobacillus plantarum 3.15 billion CFU + Lactobacillus fermentum 1.35 billion CFU + Bifidobacterium animalis 4.28 billion CFU + Bifidobacterium breve 1.35 billion CFU + Bifidobacterium bifidum 225 million CFU + Streptococcus thermophilus 2.25 billion CFU capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|